George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Mr A
Late reply, don’t pop in so often.
Website
We have also established commercial relationships with IVD companies worldwide to improve the clinical utility of diagnostic testing solutions, by combining bespoke Affimer® reagents with leading diagnostic platform technologies.
As I say, not a lot of detail. Just waffle.
They would be better off selling off diagnostic usage to someone who is interested in taking final product to market. Nothing wrong in focusing on help solve cancers.
Main issue the the LFD is it throws managements capabilities into doubt. Car crash compared to promises. It’s fairly obvious they need to boost the team from 2020 with some experience. Need more than “build it, they will come approach”. IMHO.
be interesting to know what other tests are in the pipe, or is diagnostics limited to just one pathogen ? if that business isn't going to be developed ditch it and go with therapeutics only.
are there any opportunities, or is the plan we have the patent, fingers crossed someone else figures out how to make a product.
Not really, market cap 36 million USD.
But yeah goes to show hii oh w right deal, even if fussy can move SP bloody quick. Anyone sitting in cash might miss out. 200 ex chinacetc, can I get my tamper badge now?
https://finance.yahoo.com/news/sona-announces-u-partnership-preliminary-202700880.html
Genuine question/discussion, up to you how you take this.?
Re it works in man.??so phase 1 is “normally” used to show safety, I think (no ideas to be honest, work with computers). Part of this is toxicology tests. Precision is aimed at lowering toxic effect esp on heart etc.??
So it’s a bit of a new case. Normally drug is tested to be safe at phase 1, and dosing is tuned, but Precision is claiming to be safer with same or better effects,, so phase 1 is a big part of total claims.??But given that toxic effects are lower at various dosages, doesn’t the trials then need to prove that the cancer treatment component is being delivered correctly and that patients are getting a better overall effect. It’s not enough to just show “it doesn’t kill anyone as fast”. Later phases must show that the cancer treatment part is released in tumour and works.
??I am not saying this the case is that the precision drug is not cleaved, but if that was the case the toxic effects would be ok but treatment would not work.??
What if patients were getting better and toxic effect were vastly reduced, could phase 1 be extended to keep treatment going until the tumour was reduced as far as possible in the patients that got it. That would seem to be ethical thing to do. Can this drug be given to those who have no option but palliative care and some last attempt if phase 1 is shown to be ok for toxicology.
Ah bugger. Pl was right. Light boy with the small chipolata managed to ride the pump and dump in time for the RNS. Rinse and repeat indeed.What a twat I am not to see how brilliant they are. Should have folllowed them instead of just holding.
Well done Donkey Team, I apologize for ever doubting you could pull one off.
Thank you but what is this windows you speak of?
I might have to upgrade the zx. ;-)
I keep thinking how we will look back in a few years and laugh as we sip g and t in PL boat parked in wetherby canal.
In it for the drugs. Test raised some cash. Down overall but thems the risks. Things take time.
Wow that’s a very loud sausage thwacking.
Good on you sir, no cut and paste for you, but a full rewrite in CAPS. Dedication, we need more of it, my hat is off to you.
Are the CAPS cos the pump and dump PLAN based on a attempt to mislead others about phase 1 dosing was badly timed and you have all been caught pants down cos of today’s RNS. Thought the September attempt was executed badly but this weeks run at it is an all time low.
Excuse me, got to go shower and change cos just had a leakage from laughing so hard.
Ask them what make of brown envelope is best. It’s more in their competence range.
he impact of suspension of sales in the UK as a result of the CTDA regulations coming into force will not have a material impact on the Company's anticipated financial outturn for the financial year ending 31 December 2021. As previously noted, Avacta continues to focus on opportunities outside of the UK for the sale and marketing of its AffiDX SARS-CoV-2 Lateral Flow Rapid Antigen Test including markets in Europe and further afield.
Odd feeling “oh we were **** at selling in home market, that’s a relief”
Im not a pharmacist
Recent post says dose escalation phase will show “it works”
Anyone know if this is what phase 1 trials show.
I looked on Wikipedia and found this
They are designed to test the safety, side effects, best dose, and formulation method for the drug
But no where did it say it proves it works. I thought that comes later
But it’s not a “new” drug. The killing bit is known to work so tumor will be hit.
If low dosage is used to start, is it enough to be more effective that current treatment or does the test dosage need to increase, abs checked again for side effects. Also how many people are needed be tested to check that results are consistent. I guess some drugs get through phase 1 but fail later ?
GLA
Your first 6 words were interesting.
Wow synchronized sausage thwacking. UK has some professional talent in Government but fair play, amateur are giving it a decent go.
Do you get sponsored by the local butcher or do you pump your own sausages freshly every day?
@vegas
He uses a script. All id point to one account eh myname+1@mail.com, myname+n@ is the same email destination action, and he just sets up new IDs.
Then when he wants 89 ticks it’s just to run a little program and an identifying string. The program logs in, set board to Avacta, runs through the chat and up votes his post, logs out and onto next id.
Takes a 14 year less than an hour to code it.
Lse has very little in the way of security.
Give away is how fast the votes appear. Whilst it’s a complete farse he gets some sort of kick from having lots of votes. He also think a it makes his wild predictions more believable, so he can sit on his donkey with sausage in hand pumping for all he is worth.
Lordship not here, what’s the wurst that could happen
It’s been popular for ages, and often with scientists. I pretty sure even in the 60s Spok was a vegan.
is this the death ligand stuff, where affirmer would stop the cancer cell hiding? That would mean Avacta has 2 potentially huge treatments. Long way to go, but if both worked it's easy worth 200 bucks ex china.
that Al is pleased with progress means diddly squat.
he was/is pleased with LFD progress
there is risk and big payoff, SP reflects those today, and its decline reflects markets opinion of Als communication about status on LFD.
Prof waffle think 40-50p fair valuation on diagnostics. Odd given Roche like valuations have been give .
As others have said it’s awesome to have part, if only throwing money at the SP, in a drug that could help so many. Bloody great. Maxed out but would buy if not at this price, otherwise.
But as a ceo, he is shocking. 120p II valuation before LFD one year ago. Has a LFD and SP is woeful. **** poor performance and he gives impression that diagnostics isn’t of any big interest. Market feels his engagement.